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Persistence of sisomicin and gentamicin in renal cortex and me-
dullacompared with other organs and serum of rats. Aminoglycoside
antibiotics seem to accumulate and persist in the kidney. For a
better understanding of this problem, groups of six rats received a
single 4 mg/kg i.p. injection of sisomicin and were sacrificed re-
peatedly from 30 mm to 28 days later. Sisomicin concentrations
(bioassay) decreased rapidly in the serum, lung and other tissues.
There was only a trace at six hours. The situation was totally
different for the kidney. Concentrations in the cortex increased up
to six hours with a ma\imum of 99 Lg/g, II times higher than the
peak value in the serum, then decreased very slowly to 56, 18, and 7
.tg/g, 2, 14 and 28 days, respectively, after injection. The concen-
trations in the medulla were lower than in the cortex but also
showed an accumulation and persistence. Similar results were ob-
served with gentamicin. In another experiment, daily injections of
sisomicin or gentamicin during seven days demonstrated that the
concentrations of both antibiotics six hours after the last injection
were nearly three times higher in the cortex and twice as high in the
medulla than after a single injection. These data explain why the
nephrotoxicity of sisomicin or gentamicin involves chiefly the cor-
tex, increases with the length of the treatment and can persist for
several weeks after the last injection. Therapeutic implications
need further studies.
Persistance de Ia sisomicine et de Ia gentamicine dans Ia corticale
et Ia médullaire dii rein chez le rat: Comparaison avec d'autres
organes et avec serum. Les aminoglucosides montrent une ten-
dance a s'accumuler et a persister dans Ic parenchyme renal. Pour
une meilleure comprehension de cette singularité, des groupes de 6
rats recoivent une dose unique de 4 mg/kg de sisomicine, puis sont
sacriflés a divers intervalles entre 30 minutes et 28 jours aprés cette
injection. Les concentrations de sisomicine, mesurées par one me-
thode microbiologique, diminuent rapidement dans Ic serum, Ic
poumon et d'autres tissus, qui n'en contiennent plus que des traces
a 6 heures. La situation est toute différente dans Ic rein. Les concen-
trations augmentent dans Ia corticale jusqu'à 6 heures, avec un
maximum de 99 izg/g, cc qui représente 11 fois les valeurs maxi-
males observées dans Ic serum; elles s'abaisent ensuite lentement
a 56, 18 et 7 g/g après 2, 14 et 28jours. Les concentrations dans Ia
médullaire sont plus faibles mais manifestent Ic mCme phénoméne
d'accumulation et de persistance. Dans un autre groupe
d'expériences, des injections quotidiennes de sisomicine ou de gen-
tamicine sont rCpétCes pendant 7 jours: 6 heures aprCs Ia derniCre
injection, les concentrations des deux antibiotiques dans Ia corti-
cale sont environ 3 fois plus élevées qu'après une dose unique; dans
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Ia médullaire, dIes sont 2 fois plus élevées qu'aprês une dose. On
comprend des lors pourquoi Ia néphrotoxicité de Ia sisomicine et
de Ia gentamicine touche surtout Ia corticale et pourquoi elle
s'affirme avec Ia durée du traitement puis se manifeste encore
plusieurs semaines après Ia derniCre injection. D'autres recherches
seront nécessaires pour définir les consequences therapeutiques de
Ia persistance des aminoglucosides dans Ic rein.
Antibiotics show remarkable variations in their
ability to concentrate in the different parts of the
kidney [1]. For example, some penicillins and ceph-
alothin concentrations are higher in the medulla than
in the cortex, especially in the hydropenic state [2, 3];
ampicillin has approximately the same concentration
in both regions [1, 3], while gentamicin [4-7] and to a
lesser degree, doxycycline [8] accumulate in the cor-
tex. These data were generally based on observations
made at one specific time only. Little is known about
the kinetics of antibiotics in the renal tissues based on
repeated observations. We recently demonstrated in
rats that ampicillin disappears rapidly from the renal
cortex, but not quite as fast from the medulla [3].
Therapeutic concentrations of doxycycline are main-
tained during more than 18 hr in the kidney and all
other organs, with practically the same rate of elimi-
nation from the serum and the various tissues [3, 8].
The situation is completely different for the amino-
glycosides. The antibiotics of this group are rap-
idly eliminated from the serum of rats, but persist in
the kidney. Luft and Kleit [4] showed that this phe-
nomenon is minimal with streptomycin, moderate
with kanamycin or tobramycin and marked with gen-
tamicin. Available data do not provide precise infor-
mation concerning the separate kinetics in the renal
cortex and medulla of the different aminoglycosides.
In our present investigation, the concentrations in
the renal cortex and medulla of the new aminoglyco-
side antibiotic sisomicin, as well as gentamicin, were
measured repeatedly in rats up to four weeks after
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administration and were compared with the pharma-
cokinetics in the serum and other tissues. Part of this
work has been presented recently in abstract form [9].
Methods
Male Wistar rats weighing about 300 g, who were
allowed free access to water, received a single i.p.
injection of 4 mg/kg of sisomicin or gentamicin. They
were sacrificed by exsanguination under ether anes-
thesia in groups of six, at intervals of 0.5, 1, 6, 12 and
24 hr, and then 2, 5, 7, 21 and 28 days after the
injection. The animals were dissected immediately
and the serum, urine, kidneys, lungs, muscle, heart,
stomach, intestine, testicle, liver and spleen were re-
moved for antibiotic determinations. The medulla
and cortex of the kidneys were separated by a careful
dissection. Section was performed through the outer
medulla, in order to avoid any cortex contamination
of the medulla. After the 12th hr, determinations
were performed only on the renal cortex and medulla,
serum and urine, since the other organs had non-
measurable quantities of antibiotic.
After the serum, urine or bile had been maximally
absorbed onto blotting paper, the tissue for analysis
was placed, without washing, into a phosphate buffer
solution at pH 8 (M/10) in proportions varying with
the tissue and the interval after injection, in order to
obtain samples of satisfactory volume and fluidity,
with adequate zones of inhibition. The final mixture
contained between 16 and 2 tg/ml of antibiotic. It
was then homogenized in an Ultraturrax.
Standards were prepared for each organ in the
same manner, utilizing the same organ from rats of
the same species and weight. Known quantities of
sisomicin or gentamicin were added to these organs
to obtain concentrations of 16, 8, 4 and 2 ig/g. An
agar plate (Nutrient Agar, 1.5%, Difco), 30 X 30cm,
inoculated with Bacillus subtiis was used for three de-
terminations and the four standards mentioned
above; each sample and each standard were present
five times on the plate, in metal cups of 8 mm in
diameter. After incubation overnight at 38°C, the
diameters of the zones of inhibition were measured.
The mean of the five measurements for each sample
or standard was calculated and a standard curve was
drawn with four standard points on semi-log paper.
The results were read directly on the curve and ad-
justed to the diluting factor. Estimations in the serum
and urine were carried out in a similar manner, with
standards of 8, 4, 2 and 1 tg/ml in rat serum or in
phosphate buffer (M/l0) at pH 8, respectively. The
required dilutions of the samples caused less accurate
results when the antibiotic per gram of tissue was less
than 6 g; when below 3 g/g in the tissues and 0.5
g/ml in the serum, they lost precision and are re-
ported as "traces."
Measurements of the hemoglobin concentrations
in the blood and the homogenates permitted an ap-
proximation of the amount of residual blood in the
tissues: 1.5% in the lung and less than 0.5% in the
other organs. This had a negligible influence on the
results of antibiotic concentrations in the tissues.
In another experiment, a group of six rats received
4 mg/kg of sisomicin intraperitoneally each 24 hr for
seven consecutive days. They were sacrificed six
hours after the last injection and studied as above.
The same experiment was repeated in six other rats
injected daily with 4 mg/kg of gentamicin for seven
days.
Half-lives were calculated by linear regression of
the mean concentrations. The statistical significance
of the differences observed between tissue concentra-
tions measured at the same time on the same group of
animals was determined according to the paired ob-
servations t test. In the other situations the unpaired I
test was applied.
Results
After a peak at 0.5 to 1 hr after injection, sisomicin
and gentamicin concentrations in the serum de-
creased rapidly (Table 1). The half-life of both drugs
was nearly 90 mm.
Concentrations in lung tissue paralleled the con-
centrations in the serum, but were slightly lower, with
a maximum of 5.2 1.9 tg/g for sisomicin (P <
0.01) and 4.3 0.7 tg/g for gentamicin (P < 0.05)
0.5 hr after injection. In the heart muscle, maximum
concentrations of sisomicin were 3.9 g/g (at 0.5 hr)
and lower for gentamicin. In muscle, stomach, in-
testine, testis, liver and spleen, the mean concentra-
tions never attained 3 g/g for both antibiotics,
which is below the limit for an accurate determina-
tion in the tissues with the method used. In all tissues
mentioned above, the presence of the antibiotics was
hardly detectable six hours after injection.
The situation was totally different in the kidney.
Concentrations of sisomicin and gentamicin in the
renal cortex increased progressively up to six hours,
with a mean maximum of 99 and 123 g/g, respec-
tively (Figs. 1 and 2, Table 1). Then they decreased
very slowly, the mean concentration still being 7 Lg/g
for both antibiotics 28 days after a single injection.
The apparent rate of disappearance from the cortex
as seen in Figs, 1 and 2 decreased with time. How-
ever, it seemed hazardous to calculate the different
exponential components of the disposition phase.
For practical purposes, the apparent half-life of elim-
ination in the cortex was estimated between the sixth
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Table 1. Antibiotic concentrations in the serum, urine (tig/ml), renal cortex and renal medulla (2g/g)
after a single i.p. injection of 4 mg/kg of sisomicin or gentamicin
0.Shr lhr 6hr Iday 2days l4days 28days
Sisomicin
Serum 8.8 + 1.2 4.7 1.2 0.45 0.4 0 0 0 0
Cortex 55±7 66±8 99±16 69±17 56±8 18±4 7±4
Medulla 50 9 36 + 11 23 3 17 4 12 3 3 I traces
Cortex
Medulla 1.1 1.8 4.3 4.1 4.7 6.0
Urine 1000 680 14.0 3.6 1.6 2.8 traces
Gentamicin
Serum 5.8 1.3 6.3 1.8 traces 0 0 0 0
Cortex 52 II 81 10 123 20 96 21 80 47 22 7 7 3
Medulla 46 13 40 7 20 2 23 5 13 9 5 + 2 traces
Cortex
Medulla 11. 20. 61 42. . 62. 44.
Urine 1300 1800 7.6 3.8 4.4 2.9 traces
Mean of six rats
hour and the third day, as well as between the fifth
and the twenty-eighth day; the calculated values for
sisomicin were 62 and 235 hr, respectively; for gen-
tamicin, they were 98 and 166 hr, respectively.
In the renal medulla, sisomicin and gentamicin
reached their maximum concentration at 0.5 hr, with
values very close to the concentration in the cortex at
the same time (Table 1). Then medullary concentra-
tions decreased with a half-life of 35 hr for sisomicin
and 55 hr for gentamicin between the 0.5 hr and the
third day, which is nearly two times more rapid than
in the cortex (Figs. 1 and 2). As a result the difference
between the concentrations in the cortex and the
medulla increased with time (Table 1).
The largest part of both antibiotics was quickly
excreted (Table 1) but small quantities could be
found in the urine until the end of the experiment.
Thus, the mean urine concentrations of sisomicin
were 680 sg/ml one hour after injection, only 14
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tg/ml at six hours and about 1 to 4 zg/ml later on.
Table 2 shows the results observed in the rats re-
ceiving 4 mg/kg of sisomicin or gentamicin daily for
seven consecutive days and sacrificed six hours after
the last injection. The concentrations of both antibi-
otics were nearly three times higher in the cortex and
twice as high in the medulla than after a single injec-
tion (P < 0.01). At the same time, the serum, lung
and muscle did not contain measurable quantities of
sisomicin or gentamicin.
Discussion
The determination of antibiotic concentrations in
the organs is difficult because of the binding or inhibi-
tion of antibacterial agents by the tissues [71. We
attempted to avoid this difficulty by employing for
each tissue separately standards prepared from iden-
tical organs of rats of the same species and age. The
results are not as precise as for the serum and urine.
I
28
0 7 14 21 28
Fig. 1. Concentrations of sisomicin in the renal cortex, renal medulla
and serum after a single i.p. injection of 4 mg/kg sisomicin. Values
are the means of six rats so.
0 7 14 21
Days
Fig. 2. Concentrations of gentamicin in the renal cortex, renal me-
dulla and serum after a single i.p. injection of4 mg/kg ofgentamicin.
Values are the means of six rats so.
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Table 2. Concentrations of gentamicin and sisomicin (g/g) in
the renal cortex and the renal medulla of rats injected daily with
4 mg/kg of gentamicin or sisomicin for seven consecutive days,
and sacrificed six hours after the last injections
Gentamicin Sisomicin
Cortex Medulla Cortex Medulla
Mean
SD
228
152
400
388
520
452
356
139
46
36
53
37
29
84
48
19
400
400
508
292
320
224
357
100
79
41
58
55
38
48
53
15
Individual values.
In the case of aminoglycoside antibiotics, they are
less accurate than for penicillin or tetracycline deriva-
tives. The technique used produced results that were
reproducible with a SD of 20%.
Even with the above-mentioned reservations, the
data presented here allow a kinetic approach to the
behavior of sisomicin and gentamicin in the tissues
and, especially, in various parts of the kidneys. There
is a striking contrast between the rapid penetration
and disappearance of both antibiotics in the serum or
lung and their accumulation and prolonged per-
sistence in the renal cortex and renal medulla. The
maximum concentrations in the cortex were not
reached before the sixth hour after injection, at a time
when sisomicin and gentamicin were undetectable in
the serum and almost totally excreted. Concentra-
tions of both antibiotics in the cortex decreased so
slowly that they remained higher than the minimum
inhibitory concentration for suspectible microorgan-
isms, namely 6 tg/g, until the fourth week after a
single injection of 4 mg/kg. This dose gave the first
day serum concentrations similar to those obtained
in clinical situations.
Both aminoglycosides also accumul2ted in the
renal medulla, but to a lesser degree than in the
cortex. Kinetics were not the same in the two parts of
the kidney, with an earlier maximum concentration
in the medulla, at 0.5 hr instead of 6 hr in the cortex.
The decrease in concentrations during the first three
days was more rapid in the medulla than in the cor-
tex. These differences which cause the cortex/medulla
concentration ratio to increase with time might better
explain the discrepancies in the literature concerning
this ratio [4-7] rather than changes in the state of
hydration or urinary pH, which do not influence the
intrarenal pattern of gentamicin, at least in the dog
[1, 7]. After a three- to four-hour infusion of 15
tg/kg/min of gentamicin, Whelton et al [7] observed
a cortex/medulla concentration ratio of 4.1 in hy-
drated dogs and of 4.5 in hydropenic dogs. con-
sequently giving values between the ratios of 2.0 and
6.1 that we observed one and six hours after injection,
respectively.
This phenomenon of accumulation is unique for
the kidney. We have observed it in no other organ
studied.
If the accumulation of aminoglycosides in the renal
cortex is well documented, their persistence in the
kidney has only been described recently by Luft and
Kleit [4]. The latter authors followed the behavior of
gentamicin in the whole kidney of dogs until the
eleventh day after an injection of 10 mg/kg. During
this period the half-life in renal tissue was 109 hr.
These data are similar to our own findings. They
separated the cortex and the medulla only at the
twelfth hour after injection: approximately 85% of
the gentamicin resided in the cortex. By extending
our observations until the fourth week after injection,
we were able t' establish that this unusual persistence
increases with time, since the elimination rate of gen-
tamicin, as well as sisomicin, from the renal cortex
and medulla is reduced with time. This could be
caused by a variable degree of binding that these
antibiotics make with various structures of the tis-
sues.
Our study broadens the knowledge of the pharma-
cokinetics of sisomicin, an aminoglycoside extracted
from micromonospora inyonensis, whose antibacte-
rial action and dosage are similar to gentamicin [11-
13]. As in the serum, this antibiotic behaves in all
tissues practically in the same manner as gentamicin.
The interpretation of renal antibiotic concentra-
tion data presents certain difficulties, since we should
know how much of the drug measured in the ho-
mogenate belongs to the tissue itself or to the urine
trapped within the tubular intraluminal space. Es-
timates can be made for the papilla using antibiotic
concentrations in the urine, but the situation in the
cortex is less clear [2]. Since the concentrations of
sisomicin and gentamicin in the urine immediately
after injection were very high, it is evident that part of
the antibiotic contained in the kidney homogenates
of 0.5 and 1 hr belonged to the urine remaining in the
tubules even with the precautions used to avoid this.
However, six hours after injection, the possible in-
fluence of tubular urine on the antibiotic concentra-
tion became very small; later it was negligible. The
same can be said for the blood remaining in the
kidney. Therefore, during the extended period in
448 Fabre et a!
which we studied the persistence of sisomicin or gen-
tamicin in the cortex and medulla, the quantities of
antibiotic measured belong almost entirely to the
renal parenchyma.
It has been shown in dogs that gentamicin dis-
appears rapidly from the renal lymph, with the same
concentrations and half-life as in the serum [14, 15].
This fact suggests that gentamicin does not accumu-
late in the interstitial fluid or the renal lymph, which
largely reflects the interstitial fluid [16], but probably
accumulates by binding onto cell membranes, organ-
elle membranes or intracellular proteins. The marked
accumulation in the cortex could be related to the
fact that gentamicin is partly excreted by tubular
secretion [17]. It is worthwhile to note that in the dog,
quinine, a competitive blocker of the proximal tubu-
lar organic base secretory system, reduced cortical
accumulation of gentamicin [1],
The pharmacokinetic approach presented in this
work shows how the accumulation of sisomicin and
gentamicin is enhanced by the persistence of these
antibiotics in the kidney. The special kinetic behavior
of these aminoglycosides predictably led to very large
concentrations in the renal cortex when the doses
were repeated. After seven daily injections of 4
mg/kg, the mean concentrations were 357 g of si-
somicin and 356 tg of gentamicin per gram of cortex,
which is almost 50 times the maximum concentra-
tions observed in the serum. At this time, the serum
contained only nonmeasurable traces of antibiotic.
Theoretical concentrations after the seventh injection
(calculated according to the peak levels and half-lives
obtained during the first day after a single injection)
were nearly 300 Mg/g for sisomicin and 450 Mg/g for
gentamicin. As can be seen from Table 1, our estima-
tions were not far from the measured amounts. Thus,
there was practically no saturation after seven days of
treatment: the capacity of the renal cortex of the rat
to accumulate sisomicin or gentamicin seems very
large. Luft et al [18] showed recently that this capac-
ity in the whole kidney reaches a plateau around 500
to 700 Mg/g in dogs receiving 60 Mg/kg/day of vari-
ous aminoglycosides over 15 days. This dosage a!-
ways caused severe toxic reactions; all animals had
serious renal lesions, as well as considerable blood
urea nitrogen (BUN) and antibiotic retention. This
gives an idea of the possibilities of accumulation; but
the conditions observed by these authors were totally
different than those of rats treated with pharma-
cological doses, without accumulation in the serum.
As anticipated, the accumulation on the seventh day
is distinctly less in the medulla (Table 1). This could
explain why the morphological manifestations of tox-
icity involve primarily the pars convoluta of the prox-
imal tubules, which comprises the largest part of the
cortex [18, 19].
Fillastre et al [20] have shown in vitro that sisomi-
cm and gentamicin cause changes in the membrane of
the lysosomes and in the respiratory processes of the
mitochondria. These disturbances only occur when
the suspension of organelles contains very high anti-
biotic concentrations. They start when the antibiotic
is at 40 g/ml of suspension and reach their full
effect at 240 Mg/mI. These values are markedly higher
than those observed in the serum of patients treated
with sisomicin or gentamicin. Our observations give
these findings their true significance by showing that
after one week of treatment the renal cortex accumu-
lates the same quantities of aminoglycosides as those
which induce severe disturbances of the cellular or-
ganelles. The noteworthy findings of electron micro-
scopy described by Luft et al [18] and Kosek, Mazze
and Cousins showed cytosegrosomes with myeloid
bodies within the proximal tubular cells [19]; these
cytosegrosomes with myeloid bodies are modified
secondary lysosomes formed by the process of cy-
toplasmic degradation [21J.
Large amounts of gentamicin are quickly excreted
by the human and animal kidney with a total elimina-
tion of 80 to 90% of the dose in 24 hr, predominantly
in the first 6 hr [4, 22, 23]. However, it was shown
that the urine contains small amounts of the antibi-
otic for many days after the end of the treatment [2,
5, 25, 26]. We confirmed this observation and demon-
strated the same phenomenon with sisomicin. The
present data give a possible explanation of this phe-
nomenon: while the largest part of the organism is
rapidly cleared of the antibiotic, the sisomicin or
gentamicin accumulated in the renal cortex is pro-
gressively and slowly discharged in the urine.
In patients, gentamicin is also found in the urine
for more than three weeks after the last injection [23].
It is therefore probable that our findings can be trans-
posed, in a relative manner, to the human subject.
This would explain why the nephrotoxicity of ami-
noglycosides increases with the length of the treat-
ment, why the toxic lesions are found in the cortex
and why they do not stop immediately after the end
of the treatment. Bioassays show that the sisomicin
and the gentamicin contained in the kidney are read-
ily diffusible. Therefore, it would be important to
determine more accurately in which structures they
accumulate, and if they reach efficient concentrations
at the critical tissue sites where microorganisms are
present in cases of pyelonephritis, This would supply
us with information on whether renal infections may
be treated with widely separated injections of these
persisting antibiotics.
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